Search Results - "Wang, Yannick"

Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma by Wang, Yannick, Wozniak, Agnieszka, Cornillie, Jasmien, Avilés, Pablo, Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick

“…A clinically relevant subset of patients with soft tissue sarcoma presents with either locally advanced or upfront metastatic disease, or will develop distant…”
Get full text

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors by Wang, Yannick, Wozniak, Agnieszka, Wellens, Jasmien, Gebreyohannes, Yemarshet K., Guillén, Maria Jose, Avilés, Pablo M., Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick

“…The majority of patients with gastrointestinal stromal tumors (GIST) eventually become resistant with time due to secondary mutations in the driver receptor…”
Get full text

Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing by Cornillie, Jasmien, Wozniak, Agnieszka, Li, Haifu, Wang, Yannick, Boeckx, Bram, Gebreyohannes, Yemarshet K, Wellens, Jasmien, Vanleeuw, Ulla, Hompes, Daphne, Stas, Marguerite, Sinnaeve, Friedl, Wafa, Hazem, Lambrechts, Diether, Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick

“…Soft-tissue sarcomas (STS) represent a heterogeneous group of rare, malignant tumors of mesenchymal origin. Reliable sarcoma research models are scarce. We…”
Get full text

Abstract 1676: Plocabulin, a novel tubulin inhibitor, has antitumor activity in various patient-derived xenograft models of soft tissue sarcoma by Wang, Yannick, Wozniak, Agnieszka, Cornillie, Jasmien, Lee, Che-Jui, Guillén, María José, Avilés, Pablo, Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick

“…Abstract Objective: Soft tissue sarcomas (STS) constitute a heterogeneous group of rare, malignant tumors arising in mesenchymal tissue. Doxorubicin…”
Get full text

Abstract 1117: XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS) and their histopathological and molecular characterization by Wozniak, Agnieszka, Van Renterghem, Britt, Cornillie, Jasmien, Wang, Yannick, Lee, Che-Jui, Wellens, Jasmien, Vanleeuw, Ulla, Nysen, Madita, Hompes, Daphne, Sinnaeve, Friedl, Wafa, Hazem, Topal, Baki, Verbelen, Tom, Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick

“…Abstract Background: STS constitutes a rare family of mesenchymal tumors with more than 70 subtypes classified by WHO (2013). The limited treatment options…”
Get full text

Abstract 1031: XenoSarc: Patient-derived xenograft (PDX) models of soft tissue sarcoma (STS)—an update on a preclinical platform for early drug testing by Wozniak, Agnieszka, Cornillie, Jasmien, Gebreyohannes, Yemarshet K., Wang, Yannick, Wellens, Jasmien, Vanleeuw, Ulla, Hompes, Daphne, Stas, Marguerite, Sinnaeve, Friedl, Wafa, Hazem, Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick

“…Abstract Background: STS constitutes a rare family of mesenchymal tumors with more than 70 subtypes described. The limited treatment options available for…”
Get full text

Abstract 3840: Plocabulin, a tubulin inhibitor, presents antitumor activity in patient-derived xenograft (PDX) models of gastrointestinal stromal tumor (GIST) by Wozniak, Agnieszka, Wang, Yannick, Wellens, Jasmien, Gebreyohannes, Yemarshet K., Guillén, Maria Jose, Galmarini, Carlos M., Avilés, Pablo M., Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick

“…Abstract Introduction: Advanced GIST is commonly treated with tyrosine kinase inhibitors (TKI) [e.g. imatinib (IMA)]. With time the vast majority of patients…”
Get full text

Abstract 3100: XenoSarc: patient-derived xenograft (PDX) models of soft tissue sarcoma (STS) and their histopathological and molecular characterization by Wozniak, Agnieszka, De Sutter, Luna, De Cock, Lore, Van Renterghem, Britt, Lee, Che-Jui, Wang, Yannick, Vanleeuw, Ulla, Verbeeck, Kimberly, Hompes, Daphne, Sinnaeve, Friedl, Wafa, Hazem, Topal, Baki, Jaekers, Joris, Van Raemdonck, Dirk, Debiec-Rychter, Maria, Sciot, Raf, Schöffski, Patrick

“…Abstract STS constitutes a family of rare mesenchymal tumors with more than 70 subtypes described. The limited treatment options available for advanced STS…”
Get full text

XenoSarc: A comprehensive platform of patient-derived xenograft (PDX) models of soft tissue sarcoma (STS) for early drug testing by Schoffski, Patrick, Van Renterghem, Britt, Cornillie, Jasmien, Wang, Yannick, Gebreyohannes, Yemarshet Kelemework, Lee, Che-Jui, Wellens, Jasmien, Vanleeuw, Ulla, Nysen, Madita, Hompes, Daphne, Stas, Marguerite, Sinnaeve, Friedl, Wafa, Hazem, Topal, Baki, Verbelen, Tom, Debiec-Rychter, Maria, Sciot, Raf, Wozniak, Agnieszka

“…Abstract only 37 Background: STS is a family of rare, heterogeneous tumors with > 70 subtypes. There is an urgent need for reliable preclinical models,…”
Get full text